Dr. Daniel Wu
Claim this profileVA Puget Sound Health Care System Seattle Division, Seattle, WA
Studies Esophageal Carcinoma
Studies Esophageal Adenocarcinoma
2 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Wu is currently running
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
Itraconazole
for Esophageal Cancer
Esophageal cancer, which has a low 5-year overall survival rate (\<20%) is increasing in incidence. Previous studies have shown that Hedgehog, AKT, and angiogenic signaling pathways are activated in a significant number of esophageal cancers. Itraconazole, a widely used anti-fungal medication, effectively inhibits these pathways. In this multi-site phase II trial, the investigators will evaluate the effect of itraconazole as a neoadjuvant therapy added to standard of care chemoradiation and surgery in the the treatment of locoregional esophageal and gastroesophageal junction cancers.
Recruiting1 award Phase 2
More about Daniel Wu
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniel Wu has experience with
- Itraconazole
- Carboplatin
- Cisplatin
- LY3537982
- Pembrolizumab
- Pemetrexed
Breakdown of trials Daniel Wu has run
Esophageal Carcinoma
Esophageal Adenocarcinoma
Esophageal Cancer
Gastroesophageal Junction Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Wu specialize in?
Daniel Wu focuses on Esophageal Carcinoma and Esophageal Adenocarcinoma. In particular, much of their work with Esophageal Carcinoma has involved treating patients, or patients who are undergoing treatment.
Is Daniel Wu currently recruiting for clinical trials?
Yes, Daniel Wu is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Daniel Wu has studied deeply?
Yes, Daniel Wu has studied treatments such as Itraconazole, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Daniel Wu?
Apply for one of the trials that Daniel Wu is conducting.
What is the office address of Daniel Wu?
The office of Daniel Wu is located at: VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington 98108 United States. This is the address for their practice at the VA Puget Sound Health Care System Seattle Division, Seattle, WA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.